Coherus Oncology Competitors and Similar CompaniesClear all
Coherus Oncology's competitors and similar companies include AstraZeneca and Pfizer.
 Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | |
Founding Date | Founding Date 2010 | Founding Date 1999 | Founding Date 1849 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Redwood City, US HQ Camarillo, US | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more |
Employees | Employees 14736% decrease | Employees 94,300 | Employees 81,0008% decrease |
Valuation ($) | Valuation ($) 85.6 m | Valuation ($) 2.7 b | Valuation ($) 163.9 b |
Financial | |||
Revenue (est.) | Revenue (est.) $42.2m (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) |
Cost of goods | Cost of goods $13.8m (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods $16.1b (FY, 2025) |
Gross profit | Gross profit $28.4m (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit $46.5b (FY, 2025) |
Net income | Net income $168m (FY, 2025) | Net income $10.2b (FY, 2025) | Net income $7.8b (FY, 2025) |
Operating ⚠ | |||
Countries | Countries N/A | Countries 130 (FY, 2021) | Countries 200 (FY, 2024) |
Phase II Trials Products | Phase II Trials Products 1 (FY, 2020) | Phase II Trials Products N/A | Phase II Trials Products 27 (FY, 2024) |
Phase III Trials Products | Phase III Trials Products 1 (FY, 2020) | Phase III Trials Products N/A | Phase III Trials Products 32 (FY, 2024) |
Projects in R&D Pipeline | Projects in R&D Pipeline 6 (FY, 2020) | Projects in R&D Pipeline 177 (FY, 2021) | Projects in R&D Pipeline N/A |
Funding | |||
Total funding raised | Total funding raised $ 174.5m | Total funding raised $ 1b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
AstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company